SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037724
Filing Date
2020-08-06
Accepted
2020-08-06 16:07:01
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20200630.htm 10-Q 2325616
2 EX-31.1 pti-ex311_7.htm EX-31.1 12088
3 EX-32.1 pti-ex321_8.htm EX-32.1 13327
  Complete submission text file 0001564590-20-037724.txt   6452452

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pti-20200630.xml EX-101.INS 1305129
5 XBRL TAXONOMY EXTENSION SCHEMA pti-20200630.xsd EX-101.SCH 35080
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20200630_cal.xml EX-101.CAL 44347
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20200630_def.xml EX-101.DEF 86881
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20200630_lab.xml EX-101.LAB 322600
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20200630_pre.xml EX-101.PRE 233448
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 201081599
SIC: 2834 Pharmaceutical Preparations